An epitope, also called an antigenic determinant, is the particular region of an antigen recognized by an antibody or an antigen receptor of the adaptive immune system. An antigen may contain many distinct or overlapping epitopes. Antibodies recognize accessible molecular surfaces directly, whereas conventional T cells recognize antigen-derived peptides displayed by specialized presenting molecules. Thus, an epitope is defined in relation to a particular recognition interaction, rather than simply being an inherent, universally recognized segment of an antigen. (ncbi.nlm.nih.gov)
Molecular basis of recognition
The distinction between antigen and epitope separates the larger molecular target from the region actually recognized. A protein antigen, for example, can present multiple surface patches to different antibodies. These patches may overlap, and their recognition depends on the antigen’s three-dimensional structure and the antibody’s binding site. The complementary antigen-binding region of an antibody is called its paratope. An epitope therefore belongs to the antigen, while a paratope belongs to the recognizing antibody. (ncbi.nlm.nih.gov)
Recognition involves complementary shape and chemical properties. Hydrogen bonds, electrostatic interactions, van der Waals forces, and hydrophobic interactions contribute to binding. Protein epitopes comprise amino acid residues, but antibody targets are not limited to proteins: carbohydrates and small chemical groups can also be recognized. There is no single epitope size or chemical composition applicable to every antigen–antibody interaction. (ncbi.nlm.nih.gov)
B-cell epitopes
B cells recognize antigens through membrane-bound immunoglobulins, which have the same basic recognition properties as secreted antibodies. Their epitopes are generally accessible portions of intact antigens; recognition does not ordinarily require the antigen to be broken into peptides first. Protein epitopes are commonly distinguished as linear or conformational. (ncbi.nlm.nih.gov)
A linear epitope consists of residues that are contiguous in the protein’s amino acid sequence. A conformational epitope consists of a surface formed by the protein’s folded structure, often bringing together residues that are separated in the sequence. Consequently, disrupting protein folding can change recognition of a conformational epitope. Antibodies raised against intact proteins frequently recognize such discontinuous surfaces, while antibodies raised against isolated peptides sometimes recognize the corresponding native protein. (ncbi.nlm.nih.gov)
“Linear” does not mean that molecular shape is irrelevant. Structural analyses show that antibody-bound peptides adopt diverse conformations, and the same peptide sequence can assume different shapes when bound by different antibodies. The distinction concerns sequence continuity, not an absence of three-dimensional recognition. (pubmed.ncbi.nlm.nih.gov)
T-cell epitopes and antigen presentation
For conventional T cells, an epitope is usually an antigen-derived peptide presented by a major histocompatibility complex molecule, or MHC molecule. The T-cell receptor contacts both the peptide and the presenting molecule. Recognition is therefore specific to a peptide–MHC combination, rather than to a free peptide alone. (ncbi.nlm.nih.gov)
MHC class I molecules generally present short peptides, commonly about 8–10 residues long, to CD8 T cells. MHC class II molecules present longer peptides to CD4 T cells. Their different binding-groove structures help explain this distinction: the class I groove constrains peptide ends, whereas the class II groove allows a peptide to extend beyond the central binding region. (ncbi.nlm.nih.gov)
Peptide generation, transport, and MHC binding influence which epitopes reach the cell surface. Certain peptide residues act as anchors within the MHC groove, while others remain available for receptor contact. Different MHC alleles have different binding preferences, so a peptide recognized in one individual may not be presented effectively in another. An antigen-presenting cell therefore displays a selected set of antigen fragments, not every possible sequence from the source protein. (ncbi.nlm.nih.gov)
Specificity, cross-reactivity, and dominance
Epitope recognition is specific but not necessarily exclusive. Cross-reactivity occurs when an antibody or receptor recognizes more than one molecular target. Related epitopes may share sufficient structural or chemical features to support binding, even when their sequences are not identical. Conversely, a mutation can alter recognition, and changes in binding need not correspond simply to overall sequence similarity. (ncbi.nlm.nih.gov)
Immune responses also differ in how strongly they target different epitopes. Immunodominant epitopes account for especially prominent recognition within a response, while other epitopes elicit weaker responses. Dominance describes the distribution of immune recognition; it is not synonymous with protection. Antibody binding alone does not establish whether an antibody prevents infection or produces another biologically effective outcome. (ncbi.nlm.nih.gov)
Experimental mapping and applications
Epitope mapping identifies the region recognized by a particular antibody or receptor. Antibody-mapping methods include overlapping peptide arrays, amino acid substitution experiments, hydrogen–deuterium exchange, and structural analysis. X-ray crystallography can reveal physical contacts in an antibody–antigen complex, while substitution experiments identify residues whose alteration affects binding. These approaches provide related but not identical information. (pmc.ncbi.nlm.nih.gov)
A loss of binding after substitution does not automatically demonstrate direct antibody contact: the alteration may instead disrupt antigen structure. Mapping experiments therefore distinguish local recognition effects from broader changes in folding or expression. Comparisons of different methods show that the apparent boundaries of an epitope can depend on the experimental approach. (nature.com)
Epitope characterization informs monoclonal antibody research and vaccine design, including the identification of conserved sites targeted by neutralizing antibodies. The Immune Epitope Database curates experimental antibody, T-cell, and MHC-related data. Its companion prediction tools estimate properties such as MHC binding and potential epitope recognition, but computational predictions are distinct from experimentally demonstrated recognition. (nature.com)